Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02943915 · ClinicalTrials.gov registry record · NA

The WISE Trial - Walking Improvement for SCI With Exoskeleton

A NA study of Injuries, Spinal Cord, sponsored by Ekso Bionics.

Completed
Registry status
NA
Development phase
45
Enrollment target
10
Study locations

NCT02943915 is a NA study of Injuries, Spinal Cord that has completed, run by Ekso Bionics. The registered enrollment target is 45 participants. The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02943915, a NA study of Injuries, Spinal Cord, has completed, sponsored by Ekso Bionics.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
10
Study locations

Study Summary

A randomized, controlled trial comparing exoskeleton gait training with standard gait training or no gait training in community-dwelling participants with chronic incomplete spinal cord injury

Conditions Studied

Interventions

  • DEVICE Ekso GT Rehabilitation Therapy
  • DEVICE Body Weight Supported (BWS) Treadmill Training

Study Locations (10)

Illinois

  • Shirley Ryan AbilityLab - Chicago
  • Marianjoy Rehabilitation Hospital - Wheaton

Arizona

  • Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix

Connecticut

  • Gaylord Hospital - Wallingford

Maryland

  • Kennedy Kruger Institute - Baltimore

Michigan

  • Rehabilitation Institute of Michigan - Detroit

Minnesota

  • Courage Kenny Research Center - Minneapolis

New Jersey

  • Kessler Foundation - West Orange

New York

  • Burke Medical Research Institute - White Plains

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2016-09
Est. Completion 2019-09-10
Phase NA

Sponsor

Ekso Bionics

3 total trials

What the Registry Record Tells You About NCT02943915

The ClinicalTrials.gov registry entry for NCT02943915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ekso Bionics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Injuries, Spinal Cord appearing as the primary indexed condition, and to 2 interventions - of which Ekso GT Rehabilitation Therapy is the first listed.

NCT02943915 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Arizona, Connecticut.

Frequently Asked Questions

What is clinical trial NCT02943915 about?

NCT02943915 is a clinical study titled "The WISE Trial - Walking Improvement for SCI With Exoskeleton". A randomized, controlled trial comparing exoskeleton gait training with standard gait training or no gait training in community-dwelling participants with chronic incomplete spinal cord injury

What is the current status of trial NCT02943915?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-09. Estimated completion is 2019-09-10.

What conditions does trial NCT02943915 study?

This clinical trial studies the following conditions: Injuries, Spinal Cord.

What interventions are being tested in trial NCT02943915?

The interventions under investigation include: Ekso GT Rehabilitation Therapy (DEVICE), Body Weight Supported (BWS) Treadmill Training (DEVICE).

Who is sponsoring clinical trial NCT02943915?

This trial is sponsored by Ekso Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02943915 being conducted?

This trial has 10 study locations across Arizona, Connecticut, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Injuries, Spinal Cord

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.